HKPD
Cellyan Biotechnology Ltd.
NASDAQ · Healthcare · Medical - Pharmaceuticals · HK
$2.19
+0.44%Price chart
Sep 30Oct 5Oct 8Oct 13Oct 16Oct 21Oct 26Oct 29
Key dataOct 29, 2026
Open$2.19
From 52W high−91.89%
Volume9064.00
Market cap$5.40M
P/E (TTM)—
P/S (TTM)0.4x
Div yield—
Key dataOct 29, 2026
Open
$2.19
From 52W high
−91.89%
Volume
9064.00
Market cap
$5.40M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−8.8x
P/E (TTM)
—
RSI (14)
39.2
MomentumView details →
1D Return
+0.44%
YTD Return
−87.08%
SummaryUpdated Mar 1, 2026
Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ:HKPD) is a recently public company that went public on January 15, 2025. Founded by Lap Sun Wong on August 17, 2023, and headquartered in Hong Kong, the company operates in the specialized niche of pharmaceutical cross-border e-commerce supply chain services. Despite being a relatively new entity, the company has established itself as a facilitator of international pharmaceutical trade, particularly focusing on over-the-counter (OTC) medications and cross-border logistics solutions.
Similar companies
Latest newsMore news →